glutamic acid has been researched along with Vascular Diseases in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Durante, W | 1 |
| Eyob, W; George, AK; Homme, RP; Sandhu, H; Singh, M; Stanisic, D; Tyagi, SC | 1 |
| Shiriaeva, IuK; Titov, VN | 1 |
| Ishii, K; Mori, A; Nakahara, T; Sakamoto, K; Tsuda, Y; Ueda, K | 1 |
| RIZKALLA, Y | 1 |
| FRANKEN, FH | 1 |
| Collignon-Robe, NJ; Haufroid, Y | 1 |
3 review(s) available for glutamic acid and Vascular Diseases
| Article | Year |
|---|---|
Glutamine Deficiency Promotes Immune and Endothelial Cell Dysfunction in COVID-19.
Topics: COVID-19; Endothelial Cells; Glutamic Acid; Glutaminase; Glutamine; Humans; Vascular Diseases | 2023 |
Regulation of the parental gene GRM4 by circGrm4 RNA transcript and glutamate-mediated neurovascular toxicity in eyes.
Topics: Animals; Cystathionine beta-Synthase; Endothelial Cells; Epigenesis, Genetic; Eye; Eye Diseases; Glutamic Acid; Homocysteine; Humans; Hyperhomocysteinemia; MicroRNAs; Receptors, Metabotropic Glutamate; RNA, Circular; Vascular Diseases | 2021 |
[Ocular vasospastic syndrome].
Topics: Apoptosis; Calcium Channel Blockers; Diagnosis, Differential; Endothelin-1; Excitatory Amino Acid Antagonists; Eye; Eye Diseases; Free Radicals; Glutamic Acid; Humans; Optic Nerve Diseases; Syndrome; Vascular Diseases | 2004 |
4 other study(ies) available for glutamic acid and Vascular Diseases
| Article | Year |
|---|---|
[The glucose, glycotoxins and glycation products: the involvement into pathogenesis of microangiopathies, arteriolosclerosis and atherosclerosis].
Topics: Arteriolosclerosis; Atherosclerosis; Diabetes Mellitus; Diabetic Angiopathies; Glucose; Glutamic Acid; Glycation End Products, Advanced; Glycosylation; Glyoxal; Humans; Metabolic Networks and Pathways; Oxidation-Reduction; Proteolysis; Pyruvaldehyde; Vascular Diseases | 2011 |
Effect of nafamostat on N-methyl-D-aspartate-induced retinal neuronal and capillary degeneration in rats.
Topics: Animals; Basement Membrane; Benzamidines; Capillaries; Diabetic Neuropathies; Excitatory Amino Acid Agonists; Glaucoma; Glutamic Acid; Guanidines; Intravitreal Injections; Male; N-Methylaspartate; Nerve Degeneration; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Retina; Retinal Diseases; Retinal Ganglion Cells; Retinal Neurons; Retinal Vessels; Serine Proteinase Inhibitors; Severity of Illness Index; Vascular Diseases | 2012 |
Glutamic acid in the treatment of cerebral arteriosclerosis and some cases of hypertension.
Topics: Arteriosclerosis; Glutamates; Glutamic Acid; Humans; Hypertension; Intracranial Arteriosclerosis; Vascular Diseases | 1955 |
[Glutamic acid-pyruvic acid transaminase in liver diseases].
Topics: Glutamic Acid; Liver Diseases; Pyruvic Acid; Transaminases; Vascular Diseases | 1957 |